(MedPage Today) — Most patients with inflammatory bowel disease (IBD) respond to initial therapy, but an estimated 10% to 40% don’t, and some others become resistant to treatment over long periods of time. For many gastroenterologists, figuring…
Source link : https://www.medpagetoday.com/spotlight/ddw-ibd/115758
Author :
Publish date : 2025-05-27 13:30:00
Copyright for syndicated content belongs to the linked Source.
